To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.
Find out MoreThis is a premium service, visit our premium services page, and subscribe to one of our Level 2 packages.
Subscribe for Seneca Growth Level 2 today!